[1]
“Effects of systemic meglumine antimoniate on ECG in patients with cutaneous leishmaniasis”, J Pak Assoc Dermatol, vol. 34, no. 4, pp. 829–835, Oct. 2024, doi: 10.66344/jpad.v34i4.2840.